Metabolon is excited to participate in the 2023 Metabolomics and Human Health Gordon Research Conference held in Lucca, Italy. European Director of Population Health, Greg Michelotti, will be presenting a poster on: Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development.
Search
Recent Posts
- ASHG 2024 Recap
- Unlocking Heart Health: How Metabolomics is Transforming the Early Detection of Myocardial Infarction
- Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders
- Metabolon Launches New “Guide to Multiomics” and Accompanying Multiomics Webinar
- Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool
Recent Comments